We are live on ! Find out more
LAI

Legal Advantage Investments Portfolio holdings

AUM $285M
1-Year Est. Return 18.63%
This Quarter Est. Return
+9.04%
1 Year Est. Return
+18.63%
3 Year Est. Return
+105.28%
5 Year Est. Return
+112.78%
10 Year Est. Return
AUM
$222M
AUM Growth
+$8.29M
Cap. Flow
-$4.51M
Cap. Flow %
-2.03%
Top 10 Hldgs %
34.53%
Holding
99
New
5
Increased
13
Reduced
23
Closed
10

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$1.34M
2
GRAL
GRAIL Inc
GRAL
+$802K
3
BA icon
Boeing
BA
+$597K
4
PANW icon
Palo Alto Networks
PANW
+$534K
5
TDG icon
TransDigm Group
TDG
+$507K

Top Sells

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$3.71M
2
PLTR icon
Palantir
PLTR
+$1.02M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$823K
4
ZBH icon
Zimmer Biomet
ZBH
+$808K
5
NTRA icon
Natera
NTRA
+$591K

Sector Composition

Rank Sector Weight
1 Technology 38.19%
2 Industrials 20%
3 Healthcare 12.73%
4 Communication Services 10.24%
5 Financials 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
76
Johnson & Johnson
JNJ
$629B
$423K 0.19%
2,282
TRV icon
77
Travelers Companies
TRV
$77.2B
$385K 0.17%
1,379
PYPL icon
78
PayPal
PYPL
$50.6B
$379K 0.17%
5,650
CRDO icon
79
Credo Technology Group
CRDO
$50B
$364K 0.16%
+2,500
New +$306K
IOT icon
80
Samsara
IOT
$22.9B
$361K 0.16%
9,700
-300
-3% -$11.1K
AFL icon
81
Aflac
AFL
$60.5B
$357K 0.16%
3,200
RIO icon
82
Rio Tinto
RIO
$165B
$353K 0.16%
5,350
BRK.B icon
83
Berkshire Hathaway Class B
BRK.B
$1.09T
$302K 0.14%
600
AZN icon
84
AstraZeneca
AZN
$246B
$272K 0.12%
1,775
GSK icon
85
GSK
GSK
$101B
$265K 0.12%
+6,150
New +$240K
HOV icon
86
Hovnanian Enterprises
HOV
$793M
$251K 0.11%
1,950
MDT icon
87
Medtronic
MDT
$116B
$223K 0.1%
2,346
-510
-18% -$46.9K
GEHC icon
88
GE HealthCare
GEHC
$32.6B
$213K 0.1%
2,830
CHKP icon
89
Check Point Software Technologies
CHKP
$13.2B
$207K 0.09%
1,000
ADBE icon
90
Adobe
ADBE
$103B
-9,595
Closed -$3.71M
BBAR icon
91
BBVA Argentina
BBAR
$3.25B
-24,000
Closed -$395K
BMA icon
92
Banco Macro
BMA
$5.1B
-7,850
Closed -$551K
NTRA icon
93
Natera
NTRA
$45.5B
-3,500
Closed -$591K
ON icon
94
ON Semiconductor
ON
$32.4B
-6,150
Closed -$322K
SUPV
95
Grupo Supervielle
SUPV
$725M
-28,645
Closed -$303K
TXN icon
96
Texas Instruments
TXN
$253B
-1,000
Closed -$208K
VCYT icon
97
Veracyte
VCYT
$3.59B
-10,976
Closed -$297K
VRTX icon
98
Vertex Pharmaceuticals
VRTX
$133B
-1,848
Closed -$823K
ZBH icon
99
Zimmer Biomet
ZBH
$18.7B
-8,860
Closed -$808K

Similar funds

Legal Advantage Investments's Q3 2025 Portfolio in Review

As of Q3 2025, Legal Advantage Investments held 99 positions worth $222M, up 3.9% from $214M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Legal Advantage Investments's Q3 2025 filing shows 5 new, 13 increased, 23 reduced and 10 closed positions. Its largest new stake was Moderna: 48,175 shares worth $1.24M. The largest sale was Adobe, an estimated $3.71M.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 40% a quarter earlier, followed by Industrials and Healthcare.

  • Legal Advantage Investments's largest Q3 2025 buy was Moderna: 48,175 shares worth $1.24M.
  • Legal Advantage Investments added most to Boeing in Q3 2025, an estimated $597K increase.
  • Legal Advantage Investments's biggest Q3 2025 reduction was Palantir, cutting an estimated $1.02M.
  • Legal Advantage Investments fully exited Adobe in Q3 2025, selling an estimated $3.71M.
  • Legal Advantage Investments's ten largest holdings make up 35% of its $222M portfolio in Q3 2025.
  • Legal Advantage Investments opened 5 new positions and closed 10 in Q3 2025.
  • Legal Advantage Investments's portfolio value rose 3.9% quarter-over-quarter to $222M.

Based on Legal Advantage Investments's 13F filing for Q3 2025, filed 20 Oct 2025.